UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
-
-
-
-
-
-
UPDATE: UBS Starts BioMarin Pharmaceutical Inc. (BMRN) at Neutral
-
-
-
-
-
-
-
BioMarin Pharmaceutical (BMRN) Price Target Raised to $112 at UBS
-
-
-
-
-
-
-
Notable Analyst Rating Changes 08/27: (WY) (MPC) (KEG) Upgraded; (LYB) (PEG) (ADSK) Downgraded
-
-
-
-
-
-
-
UBS Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Neutral
-
-
-
-
-
-
-
UBS Initiates Coverage on BioMarin Pharma (BMRN) with a Neutral
169,931 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

